Skip to main content

IPHA · Innate Pharma SA · Documents

Track IPHA — free
$1.39 +0.06 (+4.51%) Play latest call Q2 2026 earnings call transcript
Market Cap
$148.56M
Shares
111.70M
Volume · Nov 4 10.67K Avg daily vol (3M) 158.14K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Apr 4
Annual report 20-F FY2023, ended Dec 31
Annual report for FY2023
Revenue 61.64M EUR ▲ 6.9% Net loss 7.57M EUR Diluted EPS -0.09 EUR
2023
Showing 101–150 of 307 documents
Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 4 filings 4 filers Visit website Investor relations